Hospital for Special Surgery Shoulder Arthroplasty Cohort
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 5/27/2018 |
Start Date: | April 2007 |
End Date: | April 2027 |
Contact: | Robert Marx, MD |
Phone: | 212-606-1645 |
Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: HSS Shoulder Arthroplasty Cohort
Total joint replacements are some of the most successful medical devices developed over the
last fifty years. They enable millions of people to remain ambulatory and pain free, with
minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements,
and 25,000 total or partial shoulder replacements were performed in the United States (HCUP
data). Future use will likely be even higher: it is estimated that by the year 2020, the
population 65 and over in developed countries will increase by 71%. Existing studies do not
provide adequate prospective data to evaluate long-term outcomes.
HSS is a world leader in total joint replacement including total shoulder arthroplasty.
However, there is no systematic follow-up or evaluation of patients who have their shoulders
replaced here.
The purpose of this study is to establish a prospective cohort of HSS total shoulder
arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing
evaluation of the results of our patients over time.
last fifty years. They enable millions of people to remain ambulatory and pain free, with
minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements,
and 25,000 total or partial shoulder replacements were performed in the United States (HCUP
data). Future use will likely be even higher: it is estimated that by the year 2020, the
population 65 and over in developed countries will increase by 71%. Existing studies do not
provide adequate prospective data to evaluate long-term outcomes.
HSS is a world leader in total joint replacement including total shoulder arthroplasty.
However, there is no systematic follow-up or evaluation of patients who have their shoulders
replaced here.
The purpose of this study is to establish a prospective cohort of HSS total shoulder
arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing
evaluation of the results of our patients over time.
Inclusion Criteria:
- 18 years or older and undergoing total shoulder arthroplasty at HSS
Exclusion Criteria:
- No other exclusion criteria. Pregnant women are eligible for the registry as this is a
non-interventional study which only involves filling out questionnaires.
We found this trial at
2
sites
535 E 70th St
New York, New York 10021
New York, New York 10021
(212) 606-1000
Phone: 646-797-8904
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
Click here to add this to my saved trials
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
Click here to add this to my saved trials